Bibliografía del artículo
1. New MI, Dupont B, Grumbach K. Congenital adrenal hyperplasia and related condition. In: Stanbury IB, Wyngaarden JB, Fredrieksen DS, Goldstein JL (eds). The metabolic basis of inherited disease, 5th ed. New York, McGraw-Hill pp. 973-1000, 1983.
2. White P, New MI, Dupont B. Congenital adrenal hyperplasia. N Engl J Med 25:150-156, 1987.
3. Speiser PW, Dupont B, Rubenstein P, Piaza A, Kastelan A, New M . High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650-657, 1985.
4. Azziz R, Dewailly P, Owerbach P. Nonclassic adrenal hyperplasia: current concepts (clinical review 56). J Clin Endocrinol Metab 78:810-815, 1994.
5. White DC, New MI. Genetic basis of endocrine disease 2: congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74:6-11, 1992.
6. Knochenbauer E, Cortet-Rudelli C, Gunnigham R, Conway-Mayers B, Dewailly D, Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab 82:479-485, 1997.
7. Chetkowski RS, Defazio J, Shamonki, Judd H, Chang R. The incidence of late onset congenital adrenal hyperplasia due to 21 hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab 58:595-598, 1984.
8. Kuttenn F, Guillin P, Girrard E, Billaud L, Vinvens M, Boucekkine C et al. Late onset adrenal hyperplasia in hirsutism. N Engl J Med 313:224-231, 1985.
9. White PC, Grossberger D, Onufer BJ, Chaplin D, New M, Dupont B et al. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Acad Sci USA 82:521-525, 1985.
10. Trakakis E. Clinical classical and molecular genetics of 21-hydroxylase deficiency. Current concepts. Archives of Hellenic Medicine 19:534-538, 2002.
11. Trakakis E, Laggas D, Salamalekis E, Greatsas G. 21-hydroxylase deficiency: From molecular genetics to clinical presentation. J Endocrinol Invest 28:187-192, 2005.
12. Rogoff D, Gomez-Sanchez CE, Foecking MF, Wortsman J, Slominski A. Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol 78:77-78, 2001.
13. Forest M. Recent advances in the diagnosis and management of CAH due to 21-hydroxylase deficiency. Human Reproduction Update 10:469-485, 2004.
14. Merke D, Bornstein S. Congenital adrenal hyperplasia. Lancet 365:2125-2136, 2005.
15. Merke D, Chrousos G, Eisenhofer G, Weise M, Keil M, Rogol A. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 343:1362-1368, 2003.
16. Beaujean D, Rosenbaum C, Muller HW, Willemsen J, Lenders J, Bornstein S. Combinatorial code of growth factors and neuropeptides define neuroendocrine differentiation in PC12 cells. Exp Neurol 184:348-358, 2003.
17. Brown J, Fishman L, Carballera A. Studies of the neuronal trans differentiation procass in cultured human pheochromocytoma cells: effects of steroids with differing functional groups on catecholamine content and cell morphology. Steroids 63:587-594, 1998.
18. Evinger M, Towle A, Park D, Lee P, Joh T. Glucocorticoids stimulate transcription on the rat phenylethanolamine N-methyltransferase gene in vivo and in vitro. Cell Mol Neurobiol 12:193-215, 1992.
19. Charmandari E, Eisenhofer G, Mehlinger S, Caplos A, Wesley R, Keil M et al. Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J Clin Endocrinol Metab 87:3031-3037, 2002.
20. Weise M, Mehlinger S, Drinkard B, Hoizers S, Eisenhofer G, Charmandari E et al. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high intensity exercise. J Clin Endocrinol Metab 59:591-597, 2004.
21. Merke DP, Fields JD, Keil MF, Vaituzis AC, Chrousos GP, Giedd JN. Children with classic congenital adrenal hyperplasia have decreased amygdala volume: potential prenatal and postnatal hormonal effects. J Clin Endocrinol Metab 88:1760-1765, 2003.
22. New MI. Nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab epub a head August 2006.
23. Srikanth MS, West BR, Ishitani M, Isaacs H Jr, Applebaum H, Costin G. Benign testicular tumors in children with congenital adrenal hyperplasia. J Pediatr Surg 27:639-41, 1992.
24. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 349:776-788, 2003.
25. Dupont B, Oberfield SE, Smithwick EM et al. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet II:1309-1311, 1997.
26. White PC, Speiser PW. CAH due to 21-hydroxylase deficiency. Endoc Rev 21:3245-3291, 2000.
27. Pollack MS, Levine LS, O'Neill CJ et al. HLA linkage and B14, DR1 Bfs haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency. Am J Hum Genet 33:540-52, 1981.
28. Levine LS, Dupont B, Lorensn F, Pang S, Pollack MS, Oberfield S et al. Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 51:1316-1324, 1980.
29. White PC, Viten A, Dupont B, New M. Characterization of frequent deletions causing 21-hydroxylase deficiency. Proc Natl Acad Sci USA 85:4436-4440, 1988.
30. Morell Y, Miller WL. Clinical and Molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 20:1-68, 1991.
31. Owerbach D, Baillard AZ, Draznin MB. Salt wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxtlase gene, CYP 21, using the polymerase chain reaction. J Clin Endocrinol Metab 74:553-58, 1992.
32. White PC. Genetics of steroid 21-hydroxylase deficiency. Rec Prog Horm Res 43:305-316, 1987.
33. Chiou SH, Hu MC, Chung BC. A messence mutation of lle172 Ò Asn or Arg356 Ò Trp causes steroid 21-hydroxylase deficiency. J Biol Chem 256:3549-3552, 1990.
34. Dracopoulou M, Maniati M, Dacou C. The spectrum of molecular defects of the CYP 21 gene in the Hellenic population: Variable concordance between genotype and phenotype in the different forms of CAH. J Clin Endocrinol Metab 86:2845-2848, 2001.
35. Speicer PW, New MI, White PC. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14DR1. N Engl J Med 319:19-23, 1988.
36. Tusie-Luna MT, Speiser PW, Dumic Ml, New MI, White PC. A mutation (Pro 30 Ò Leu) in CYP 21 represents a potential non-classic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 5:685-692, 1991.
37. Owerbach D, Sherman L, Ballard A, Azziz R. Pro-453 Ò Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. Mol Endocrinol 6:1211-1215, 1992.
38. Dardis A, Bergada I, Rivaola M, Belgoroski A. Mutations of steroid 21-hydroxylase gene in an American population of 36 patients with classical congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 82:3293-3297, 1997.
39. Fardella C, Pogge H, Pindela P, Soto J, Torrealba L, Cattani A et al. Salt-wasting congenital adrenal hyperplasia: detection of mutation in CYP21B gene in a Chilean population. J Clin Endocrinol Metab 83:3357-3360, 1998.
40. Bachega T, Billerback A, Madureira G, Marcondes J, Longui C, Leite M et al. Molecular genotyping in Brazilian patients with the classical forms of 21- hydroxylase deficiency. J Clin Endocrinol Metab 83:4416-4419, 1998.
41. Kharrat M, Tardy V, M'Rad R, Maazoul F , Jemaa L, Refai M et al. Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab 89:368-374, 2004.
42. Brodie B, Wentz A. Late onset congenital adrenal hyperplasia: a gynecologist's perspective. Fertil Steril 48:178-88, 1987.
43. Chryssikopoylos A, Sarandakou A, Phocas I, Rizos D, Trakakis E, Zervas I. Hormonal profiles and HLA typing in a family with non-classical 21- hydroxylase deficiency. Recent Developments in Fertility and Sterility Series. Edited by Y. Boutalemb and A. Gzouli. The Parthenon Publising Group 198:53-58, 1990.
44. Trakakis E, Chryssikopoulos A, Phocas I, Sarandakou A, Rizos D. The incidence of 21-hydroxylase deficiency in Greek hyperandrogenic women: screening and diagnosis. Gynecol Endocrinol 12:89-96, 1998.
45. Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D et al. Late onset steroid 21-hydroxylase deficiency: a variant of clasisical CAH. J Clin Endocrinol Metab 55:817-827, 1982.
46. Fife D, Rappaport EB. Prevalence of salt-losing among congenital adrenal hyperplasia patients. Clin Endocrinol 19:259-264, 1993.
47. Trakakis E, Chryssikopoulos A, Sarandakou A, Phocas I, Rizos D, Gregoriou O et al. Hypothalamic-Pituitary-Thyroidal axis dysfunction and cortisol secretion in patients with non classical congenital adrenal hyperplasia. Int J Fertil 46:37-41.
48. Knochenbauer E, Cortet-Rudelli C, Gunnigham R, Conway-Mayers B, Dewailly D, Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab 82:479-485, 1997.
49. Lajic S, Clauin S, Robins T, Vexiau P, Blanche H, Bellanne C et al. Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab 87:2824-2829, 2002.
50. Speiser PW, Knochenhauer ES, Dewailly D, Fruzzeti F, Marcondes J, Azziz R. A multicenter study of women with nonclassical congenital adrenal hyperplasia: Relationship between genotype and phenotype. Mol Gen Metab 5:27-34, 2000.
51. Wilson R, Mercano A, Cheng K, New M. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80:2322-2329, 1995.
52. Rumsby G, Avey C, Conway G, Honour J. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms. Clin Endocrinol (Oxf) 48:707-11, 1998.
53. Speiser PW. Molecular diagnosis of CYP21 mutations in CAH: Implications for genetic counseling. Am J Pharmacogenomics 1:101-110, 2001.
54. Pinto G, Tardy V, Trivin C, Thalassinos C, Lordat S, Nihoul C et al. Follow up of 68 children with congenital adrenal hyperplasia due to 21 hydroxylase deficiency: revelance of genotype to management. J Clin Endocrinol Metab 88:2624-2633, 2003.
55. Deneux C, Tardy V, Dib A, Mornet E, Billaud L, Charron D et al. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 86:207-13, 2001.
56. Dolzan V, Solyon J, Fekete G, Kovacs J, Rakosnikova V, Votara F, et al. Mutational spectrum of steroid 21-hydroxylase and the genotype- phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 153:99-106, 2005.
57. Coleman MA, Honour JW. Reduced maternal dexamethazone dosage for the prenatal treatment of CAH. BJOG 111:176-178, 2004.